Disulfiram Is Effective against Drug-Resistant Mycobacterium abscessus in a Zebrafish Embryo Infection Model.
Publication/Presentation Date
11-15-2022
Abstract
Mycobacterium abscessus is an emerging nontuberculous mycobacterium (NTM) pathogen infecting susceptible people with cystic fibrosis (CF) and non-CF bronchiectasis. Here, we demonstrated the activity of an FDA-approved drug, disulfiram, against drug-susceptible and drug-resistant M. abscessus strains utilizing
Volume
66
Issue
11
First Page
0053922
Last Page
0053922
ISSN
1098-6596
Published In/Presented At
Winters, C. G., Basnet, R. M., Faasuamalie, P. E., Shallom, S. J., Zelazny, A. M., Gupta, S., & Olivier, K. N. (2022). Disulfiram Is Effective against Drug-Resistant Mycobacterium abscessus in a Zebrafish Embryo Infection Model. Antimicrobial agents and chemotherapy, 66(11), e0053922. https://doi.org/10.1128/aac.00539-22
Disciplines
Education | Medical Education
PubMedID
36197094
Department(s)
Department of Education
Document Type
Article
COinS